Haleos Labs Ltd.

As of June 30, 2026, Haleos Labs Ltd. carries a market capitalization of 4.18B, placing it among publicly traded companies globally. Its enterprise value stands at 4.18B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Haleos Labs Ltd. has 3.02M shares outstanding.

As of June 30, 2026, Haleos Labs Ltd. trades at a trailing price-to-earnings ratio of 26.49.

As of June 30, 2026, Haleos Labs Ltd. trades at an EV/EBITDA multiple of 10.23 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.29 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 16.73 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 4.18B versus a market cap of 4.18B, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The company generates approximately 5.39M in revenue per employee across its workforce of 601.50, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Haleos Labs Ltd. recorded 63.57M in income tax expense. That works out to an effective tax rate of 29.41, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 216.15M, leaving 158.02M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Haleos Labs Ltd.'s stock has gained approximately 44.22% over the past 52 weeks. The 50-day moving average sits at 1,526.77, while the 200-day moving average is 1,403.00.

Over the twelve months ended June 30, 2026, Haleos Labs Ltd. generated 3.24B in revenue and converted that into 158.02M in net income, yielding earnings per share of 50.46. EBITDA reached 408.99M, while operating income came in at 250.09M.

Over the twelve months ended June 30, 2026, Haleos Labs Ltd. posted a gross margin of 39.07, reflecting its pricing power and cost economics. The operating margin of 7.71 and net profit margin of 4.87 provide insight into operational efficiency.